PMN SCHEDULE 13G/A: SEC filing
An institutional or individual filer
Filed with the SEC on · accession 0001172661-26-003535
PMN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.5% by the first close after the filing.
Summary of the filing
An institutional or individual filer submitted an amended Schedule 13G disclosing their beneficial ownership position in ProMIS Neurosciences Inc. The filing indicates a passive investment stake with no stated intent to influence company control.
Key details
How PMN stock reacted
Close before
$14.79
Aug 13, 2026
First close after
+0.47%
$14.86
5 trading days
-0.20%
$14.76
Since filing
-76.67%
$3.45
✦ Ask GOAX AI about this filing — what it means for PMN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PMN?
Click hereFrequently asked questions
What did PMN file with the SEC on Aug 14, 2026?
PMN filed a SCHEDULE 13G/A (SEC filing). An institutional or individual filer submitted an amended Schedule 13G disclosing their beneficial ownership position in ProMIS Neurosciences Inc. The filing indicates a passive investment stake with no stated intent to influence company control.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did PMN stock react to this filing?
PMN closed at $14.79 before the filing and $14.86 on Aug 14, 2026 (+0.47%). Five trading days later: $14.76 (-0.20%).
Other PMN SEC filings
Get alerts when PMN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days